Abstract: SA-PO152
Patient Motivation Scoring and Outcomes in the Diabetes CKD Clinic
Session Information
- Diabetic Kidney Disease: Clinical - II
October 27, 2018 | Location: Exhibit Hall, San Diego Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Diabetic Kidney Disease
- 602 Diabetic Kidney Disease: Clinical
Authors
- Hickson, LaTonya J., Mayo Clinic, Rochester, Minnesota, United States
- Thorsteinsdottir, Bjoerg, Mayo Clinic, Rochester, Minnesota, United States
- Mara, Kristin C., Mayo Clinic, Rochester, Minnesota, United States
- Upadhyaya, Sudhi, Mayo Clinic, Rochester, Minnesota, United States
- Lee, Minji, Mayo Clinic, Rochester, Minnesota, United States
- Zand, Ladan, Mayo Clinic, Rochester, Minnesota, United States
- Enders, Felicity T., Mayo Clinic, Rochester, Minnesota, United States
- Canzanello, Vincent J., Mayo Clinic, Rochester, Minnesota, United States
Background
Given the global CKD burden, innovative methods to improve patient’s perception of autonomy and self-care are needed. We examined the association of variables in a patient motivation “Kidney and Heart Health” (KHH) Scoring system on CKD progression.
Methods
Diabetic-CKD (DM-CKD) patients were treated in a single-center, specialized clinic combining consultation from 1) hypertension-trained nurses and 2) physician/advanced practitioners. At each visit, patients were assigned points for meeting lifestyle (tobacco use, weight loss, alcohol use, exercise, and healthy diet) and objective (blood pressure, hemoglobin, LDL cholesterol, bone mineral metabolism, proteinuria, hemoglobin A1c, aspirin use) goals. CKD progression composite endpoint was defined as eGFR<10, dialysis, kidney transplant, or 40% reduction baseline eGFR. Time dependent cox hazards regression models examined the association between each KHH goal and CKD progression.
Results
From 2010-2016, 422 DM-CKD (eGFR 10-60mL/min/1.73m2 inclusion) patients were treated; 61% male, 91% white, mean Charlson index 8.7±3.5, mean eGFR 31.8 ±12.1. Mean KHH score was 8.8±3.5 (out of 12). KHH categories with <75% patients reaching goal were: LDL (68%), weight (68%), bone metabolism (63%), exercise (51%), hemoglobin A1c (47%), and proteinuria (43%). Over 2.6 years (median), 177 met CKD progression composite endpoint (86 dialysis, 26 transplant, 53 eGFR <10, and 127 had 40% reduction eGFR). 82 died. Univariate hazard ratios for each category are shown, Figure. Multivariable models revealed older age, achieving BP, LDL, hemoglobin, bone metabolism, and exercise goals significantly associated with lower risk of CKD progression while weight and lower eGFR associated with higher risk compared to those not meeting lifestyle or objective goals.
Conclusion
Patient motivation scores used in a specialty CKD clinic relate to observed DM-CKD progression outcomes.
Funding
- NIDDK Support